Telegram RegisterThe public register of Telegram
Telegram profile photo for Pharmacotherapy Transcripts

Channel

Pharmacotherapy Transcripts

@pharmaboardtranscripts

On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry

247subscribers

+1 since we began measuring on 26 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1002698360473
TypeChannel
Username@pharmaboardtranscripts
CreatedBetween 1 March 2025 and 31 July 2025 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded26 August 2026
Last confirmed live12 September 2026
Measurements held4
Confirmed unchanged1 time, most recently 12 September 2026
On Telegramt.me/pharmaboardtranscripts

Growth

24624824726 August 2026 — 246 subscribers27 August 2026 — 246 subscribers4 September 2026 — 248 subscribers12 September 2026 — 247 subscribers26 August 202612 September 2026
4 measurements spanning 16 days, net +1. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 246–248 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
12 Sept 2026, 00:38247-1
4 Sept 2026, 07:15248+2
27 Aug 2026, 09:42246no change
26 Aug 2026, 19:31246first reading

Engagement

20 posts held, back to 16 August 2025the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 9 September 2025. An engagement rate over an empty window would be a number about nothing.

Reaction mix

4 reactions across 3 posts, in 1 kind.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
4100.0%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 3 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 4 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 20 most recent posts we hold, published 16 August 2025 to 9 September 2025, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

9 Sept 2025, 15:47 UTC216 viewsread 26 August 2026

you know if we connect this to the bigger picture understand these specific therapeutic differences, these nuances, especially for different patient groups like pregnant women. It's not just about getting the answer right. That's about safety. It's about optimal patient safety. And it really empowers you as the pharmacist to confidently navigate these complex situations, ask the right questions, and truly be an ind

9 Sept 2025, 15:47 UTC210 viewsread 26 August 2026

One last time to thyroid nodules and goiters. These seem really common. Incredibly common. Nodules are often found incidentally just by chance on imaging done for other reasons. And anyone with a goer and enlarged thyroid needs checking. Yes, they're at higher risk for underlying thyroid dysfunction. So they should always be screened with a TSH level at minimum. When do nodules or goiters become a problem? Usual

9 Sept 2025, 15:47 UTC111 viewsread 26 August 2026

What about just managing the symptoms, the racing heart, the anxiety? That's where beta blockers come in. Drugs like propranol, aenol, metoprolol. They don't fix the underlying thyroid problem, but they help manage the adinuric symptoms like palpitations, tacicardia. Exactly. Need caution in patients with asthma or heart failure though. Interestingly, propranolol and another one natalol can also slightly decrease

9 Sept 2025, 15:47 UTC81 viewsread 26 August 2026

But the FT4 and FT3 are still in the normal range. Is that common? Surprisingly common. And it's a known, often silent risk factor for atrial fibrillation. Ah, so not benign then. Definitely not. Especially in certain groups. Treatment is usually indicated for older or frail patients, anyone with AIB risk factors, osteoporosis, or if they're clearly symptomatic, even with normal hormones. And the emergency here i

9 Sept 2025, 15:47 UTC70 viewsread 26 August 2026

What about patients already on LT4 when they get pregnant? Good question. They need to increase their dose almost immediately. The usual advice is two extra tablets per week as soon as they have a positive pregnancy test. two extra per week. Why such a jump? Because pregnancy increases thyroid binding globbulins. These proteins bind up more thyroid hormone. So you need a higher dose, sometimes up to 50% higher to m

9 Sept 2025, 15:47 UTC70 viewsread 26 August 2026

then you add the free T4 and free T3 to get the full story. What about antibodies like anti-TPO? We generally only test for those if the result is actually going to change how we manage the patient, like in specific situations. Yeah. For instance, there's some debate in cases of recurrent spontaneous abortion, but honestly, that usually requires specialist consultation. Got it. And here's a really practical tip

9 Sept 2025, 15:47 UTC84 viewsread 26 August 2026

بیماری های تیرویید Welcome to the deep dive, your shortcut to being wellinformed. Today we're plunging into uh really a vital topic for Canadian pharmacists. Absolutely. Whether you're a PBC candidate prepping hard for exams, or you're already in practice and want to keep sharp. Imagine, you know, a patient walks in tomorrow, vague symptoms, maybe fatigue, maybe weight changes. Yeah. It could be anything. Could

8 Sept 2025, 21:59 UTC90 viewsread 26 August 2026

How would a pharmacist even, you know, come across a patient needing set melanotide given how rare these genetic conditions are and what are the key details for it? That's a good point. Set melanotide is indicated specifically for bard beetle syndrome, BBS or for obesity. D to confirm deficiency in BOMC, PCSK1 or LAPR genes. These are genetic disorders that cause severe obesity starting very early in life. So while

8 Sept 2025, 21:59 UTC77 viewsread 26 August 2026

That's a totally different approach and it's an oral tablet. Right? Nrexone plus bupropion which is sold as contra is definitely different. It combines an opioid antagonist Nrexone with an inhibitor of dopamine and norapenophrne reuptake bupropion. So the nrexone part might help curb cravings while bipropene works more on the brain's reward pathways and appetite control centers. Sort of a two-pronged attack. on hung

8 Sept 2025, 21:59 UTC79 viewsread 26 August 2026

So for Canada, what are the official indications and what dose are we looking at typically? Okay, so in Canada, the indication is for adults with a BMI of 30 kgometers or more or it can be a BMI of 27 kilgram or more if they also have at least one weight related health issue like say hypertension, type 2 diabetes or dysipidemia. The maintenance dose is usually between 5 and 15 milligrams given as a subcutaneous inje

8 Sept 2025, 21:59 UTC104 viewsread 26 August 2026

چاقی Welcome everyone to the deep dive. Today we're really getting into something vital in healthcare. Um the pharmacological side of obesity treatment. It's you know constantly evolving. And whether you're practicing or maybe studying for the PBC exams, this is need to know stuff. We want clarity, accuracy, and well practical insights. Exactly. Our goal here is basically to unpack the key info from the reference ma

16 Aug 2025, 03:36 UTC152 viewsread 26 August 2026

We have certainly covered a massive amount of information today from the basics of diabetes diagnosis monitoring all the way through insulins, non-inssulin agents, special situations like pregnancy, emergencies like DKA and those targets and comprehensive care strategies. We really hope this deep dive gives you our PBC candidates the key insights distilled from the therapeutic choices reference that clarity and accu

Showing the 12 most recent of 20 posts we hold for @pharmaboardtranscripts. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Mentions

Named by 2 registered channels — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 12 September 2026 — this entry's latest reading, not the date you are reading this.

“Pharmacotherapy Transcripts” (@pharmaboardtranscripts), 247 subscribers as measured 12 September 2026. Telegram Register, tgregister.com/channel/pharmaboardtranscripts.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.